Literature DB >> 26726973

Revision Rate and Risk Factors After Lower Extremity Amputation in Diabetic or Dysvascular Patients.

Florian Wanivenhaus, Flavien Mauler, Teresa Stelzer, Alois Tschopp, Thomas Böni, Martin C Berli.   

Abstract

This article reports the revision rate and possible risk factors for lower extremity amputations in patients with diabetes mellitus or peripheral arterial disease (PAD). Data were collected from 421 patients with diabetes mellitus or PAD who underwent amputations of the lower extremity at the authors' institution from 2002 to 2012. There was a 25.2% overall revision rate. Mean time from amputation to revision was 244 days (range, 2-2590 days). Patients with diabetes mellitus had a significantly higher rate of revision to a more proximal level compared with patients without diabetes mellitus (type 1: odds ratio [OR]=3.73; 95% confidence interval [CI], 1.21-11.52; P=.022; and type 2: OR=2.3; 95% CI, 1.07-4.95; P=.033). A significant increase in revision rates was observed from Fontaine stage 0 to IV (stage 0: 17.9%; stage IV, 34.7%; P=.03). Risk factors for revision were diabetic nephropathy (OR=2.26; 95% CI, 1.4-3.63; P=.001) and polyneuropathy (OR=1.68; 95% CI, 1.03-2.73; P=.037). Patients who underwent revision amputation had a significantly younger mean age than patients who did not undergo revision amputation (65.23 years [range, 40-92 years] vs 68.52 years [range, 32-96 years]; P=.013). Anticipated amputation in this patient population requires a multidisciplinary approach with optimization of the patient's health. In the authors' clinical practice, the determination of the appropriate amputation level is performed individually for each patient, considering the risk factors identified in this study and the patient's expected mobilization potential, social background, and acceptance of a more proximal primary amputation level. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Year:  2015        PMID: 26726973     DOI: 10.3928/01477447-20151222-14

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  3 in total

1.  N-Acetylcysteine accelerates amputation stump healing in the setting of diabetes.

Authors:  Mohamed A Zayed; Xiachao Wei; Kyoung-Mi Park; Larisa Belaygorod; Uzma Naim; Joseph Harvey; Li Yin; Kendall Blumer; Clay F Semenkovich
Journal:  FASEB J       Date:  2017-03-09       Impact factor: 5.191

2.  Is Reconstruction of Unstable Midfoot Charcot Neuroarthropathy Cost Effective from a US Payer's Perspective?

Authors:  Rachel H Albright; Robert M Joseph; Dane K Wukich; David G Armstrong; Adam E Fleischer
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

3.  Cigarette Smoking Impairs Adipose Stromal Cell Vasculogenic Activity and Abrogates Potency to Ameliorate Ischemia.

Authors:  Daria Barwinska; Dmitry O Traktuev; Stephanie Merfeld-Clauss; Todd G Cook; Hongyan Lu; Irina Petrache; Keith L March
Journal:  Stem Cells       Date:  2018-03-28       Impact factor: 6.277

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.